St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...
As many as 1 in 4 cancers are driven by mutations in the SWI/SNF chromatin-remodeling complex, which controls access to DNA.
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate. It ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer - and how restoring ...
Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the search to treat the most difficult, recalcitrant cases ...
Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon ...
8don MSN
Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity
Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the ...
OverT builds scalable, cost-effective immune therapies for solid tumors using its data-driven discovery platformsNEW YORK--(BUSINESS WIRE)--#Biotech--OverT Bio, a biotechnology company developing next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results